Stay updated with breaking news from Aciphex Sprinkle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A The latest price target for Aytu BioPharma (NASDAQ: AYTU) was reported byCantor Fitzgerald on 2021-03-30. The analyst firm set a price target for11.00 expecting AYTU to rise to within 12 months (a possible 121.49% upside). 1 analyst firms have reported ratings in the last year. Q A The stock price for Aytu BioPharma (NASDAQ: AYTU) is $4.9664 last updatedToday at 1:59:40 PM. Q A Q A Q A Popular Channels
Company's 52-week low was at $0.82 Price action over last quarter: down 38.39% Company Description Aytu BioPharma Inc is a specialty pharmaceutical company commercializing novel products addressing patient needs. The company markets a portfolio of prescription products addressing large therapeutic markets. The primary care portfolio includes Natesto, the only FDA-approved nasal formulation of testosterone, ZolpiMist, the only FDA-approved oral spray prescription sleep aid, and Tuzistra XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The pediatric portfolio includes AcipHex ...